Voruciclib, a potent inhibitor of CDK9, is a clinical stage drug candidate being explored in combination with standard therapies for the treatment of hematologic malignances and solid tumors. ME-344. Mitochondrial Inhibitor. ME-344, a mitochondrial inhibitor, is a clinical stage drug candidate being evaluated for the treatment of solid tumors.